Franklin Genomic Advancements ETF (HELX)

BATS: HELX · Real-Time Price · USD
28.12
+0.07 (0.23%)
Jul 3, 2025, 1:00 PM - Market closed
-10.12%
Assets $11.19M
Expense Ratio 0.50%
PE Ratio 26.71
Shares Out 400,000
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date n/a
Payout Frequency n/a
Payout Ratio n/a
Volume 200
Open 28.12
Previous Close 28.05
Day's Range 28.12 - 28.12
52-Week Low 23.74
52-Week High 33.98
Beta 1.05
Holdings 67
Inception Date Feb 25, 2020

About HELX

Fund Home Page

The Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. HELX was launched on Feb 25, 2020 and is issued by Franklin Templeton.

Asset Class Equity
Category Health
Region Global
Stock Exchange BATS
Ticker Symbol HELX
ETF Provider Franklin Templeton

Top 10 Holdings

38.86% of assets
Name Symbol Weight
Natera, Inc. NTRA 6.31%
Vertex Pharmaceuticals Incorporated VRTX 4.23%
Samsung Biologics Co.,Ltd. 207940 4.23%
Guardant Health, Inc. GH 3.84%
Alnylam Pharmaceuticals, Inc. ALNY 3.79%
Krystal Biotech, Inc. KRYS 3.46%
Corteva, Inc. CTVA 3.39%
Medpace Holdings, Inc. MEDP 3.26%
Eli Lilly and Company LLY 3.19%
Insmed Incorporated INSM 3.18%
View More Holdings

Performance

HELX had a total return of -10.12% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.00%.

News

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

5 weeks ago - Seeking Alpha

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US admini...

4 months ago - Seeking Alpha

Can Health Care Stocks Outperform Again In 2023?

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

2 years ago - Seeking Alpha

Why Now Could Be The Time To Consider Neuroscience Investments

Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomic...

3 years ago - Seeking Alpha